辅助卡里普拉辛配方限制在严重抑郁症中产生的影响
Nadia Nabulsi, François Laliberté1, Enrico Zanardo
1Groupe d'analyse, Ltée, 1190 avenue des Canadiens-de-Montréal, Tour Deloitte, Suite 1500, Montréal, Québec H3B 0G7, Canada.
The American journal of managed care
|July 24, 2025
概括
大型抑郁症 (MDD) 患者对辅助卡里普拉的表格拒绝导致住院率显著上升. 这些限制可能会对患者的结果产生负面影响,并增加医疗保健资源利用率.
科学领域:
- 精神病学和心理健康 精神病学和心理健康
- 卫生经济学与研究成果研究成果
- 药物经济学 药物经济学
背景情况:
- 重度抑郁症 (MDD) 治疗通常涉及辅助疗法,以改善患者的治疗结果.
- 卡里普拉辛 (Vraylar) 是一种非典型的抗精神病药物,用于MDD的辅助治疗.
- 形式上的限制可能会影响患者获得必要药物的机会.
研究的目的:
- 评估与配方卡里普拉辛相关的申请拒绝对MDD患者医疗保健资源利用 (HCRU) 的影响.
- 为了比较最初被拒绝或被批准的卡里普拉辛要求的患者之间的HCRU.
主要方法:
- 基于索赔的回顾性分析使用Symphony健康综合数据集 (2015年3月至2020年10月).
- 确定了服用抗抑郁药的成年MDD患者,最初的卡里普拉索赔 (被拒绝或批准).
- 匹配的队列 (1:2) 使用倾向分数;分析了所有原因和心理健康 (MH) 相关的HCRU (住院治疗,急救诊所访问,门诊访问).
主要成果:
- 拒绝的队列 (n=566) 与批准的队列 (n=1132) 相比,所有原因 (RR=1.61) 和与MH相关的住院病例 (RR=1.89) 的比例显著更高.
- 队列之间,急诊室和门诊诊所的访问率是相似的.
- 大多数 (68.4%) 被拒绝索赔的患者从未接受过卡里普拉辛,接受过卡里普拉辛的患者平均延迟了6个月.
结论:
- 对MDD的辅助卡里普拉的形式限制与住院率的增加有关.
- 这些限制可能会对患者健康和医疗资源利用产生负面下游影响.
- 确保获得适当的辅助疗法,如卡里普拉辛,对于有效管理MDD至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
358
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
358
01:25Antidepressant Drugs: Overview
762
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
762
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
580
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
580
01:20Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
01:26Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
01:24Mania and Antimanic Drugs: Overview
321
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
321